Literature DB >> 36267825

New-onset atypical fulminant type 1 diabetes after COVID-19 vaccination: A case report.

Takaaki Kobayashi1, Fumiyoshi Yakou1, Masuo Saburi1, Ai Hirose1, Hiroaki Akaoka1, Yusuke Hirota1, Daisuke Yunaiyama2, Nobuteru Asahi1, Atsushi Ohno1, Takaya Matsushita1.   

Abstract

Adverse reactions, including the onset of diabetes, after coronavirus disease 2019 (COVID-19) vaccination have been reported. Herein, we report a case of a man who developed anti-glutamic acid decarboxylase (GAD) antibody-positive fulminant type 1 diabetes 15 weeks after COVID-19 vaccination, atypical of the previously reported anti-GAD antibody-negative cases.
© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Entities:  

Keywords:  COVID‐19 vaccination; anti‐glutamic acid decarboxylase (GAD) antibody; diabetic ketoacidosis; fulminant type 1 diabetes

Year:  2022        PMID： 36267825      PMCID： PMC9576963          DOI： 10.1002/ccr3.6473

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN： 2050-0904


  16 in total

1.  A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group.

Authors:  A Imagawa; T Hanafusa; J Miyagawa; Y Matsuzawa
Journal:  N Engl J Med       Date:  2000-02-03       Impact factor: 91.245

2.  Development of fulminant Type 1 diabetes with thrombocytopenia after influenza vaccination: a case report.

Authors:  H Yasuda; M Nagata; H Moriyama; H Kobayashi; T Akisaki; H Ueda; K Hara; K Yokono
Journal:  Diabet Med       Date:  2012-01       Impact factor: 4.359

3.  Diffusion-weighted magnetic resonance imaging in the pancreas of fulminant type 1 diabetes.

Authors:  Ayumi Tokunaga; Akihisa Imagawa; Hiroshi Nishio; Satoshi Hayata; Iichiro Shimomura; Norio Abiru; Takuya Awata; Hiroshi Ikegami; Yasuko Uchigata; Yoichi Oikawa; Haruhiko Osawa; Hiroshi Kajio; Eiji Kawasaki; Yumiko Kawabata; Junji Kozawa; Akira Shimada; Kazuma Takahashi; Shoichiro Tanaka; Daisuke Chujo; Tomoyasu Fukui; Junnosuke Miura; Kazuki Yasuda; Hisafumi Yasuda; Tetsuro Kobayashi; Toshiaki Hanafusa
Journal:  Diabetol Int       Date:  2018-04-12

4.  Two Cases of Graves' Disease Following SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome Induced by Adjuvants.

Authors:  Olga Vera-Lastra; Alberto Ordinola Navarro; Maria Pilar Cruz Domiguez; Gabriela Medina; Tania Ivonne Sánchez Valadez; Luis J Jara
Journal:  Thyroid       Date:  2021-05-03       Impact factor: 6.568

5.  Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012).

Authors:  Akihisa Imagawa; Toshiaki Hanafusa; Takuya Awata; Hiroshi Ikegami; Yasuko Uchigata; Haruhiko Osawa; Eiji Kawasaki; Yumiko Kawabata; Tetsuro Kobayashi; Akira Shimada; Ikki Shimizu; Kazuma Takahashi; Masao Nagata; Hideichi Makino; Taro Maruyama
Journal:  J Diabetes Investig       Date:  2012-11-30       Impact factor: 4.232

6.  COVID-19 Vaccine and Hyperosmolar Hyperglycemic State.

Authors:  Mohammed A Abu-Rumaileh; Ahmad M Gharaibeh; Naser Eddin Gharaibeh
Journal:  Cureus       Date:  2021-03-26

7.  A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination.

Authors:  Armando Patrizio; Silvia Martina Ferrari; Alessandro Antonelli; Poupak Fallahi
Journal:  J Autoimmun       Date:  2021-10-12       Impact factor: 7.094

8.  Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.

Authors:  Einav G Levin; Yaniv Lustig; Carmit Cohen; Ronen Fluss; Victoria Indenbaum; Sharon Amit; Ram Doolman; Keren Asraf; Ella Mendelson; Arnona Ziv; Carmit Rubin; Laurence Freedman; Yitshak Kreiss; Gili Regev-Yochay
Journal:  N Engl J Med       Date:  2021-10-06       Impact factor: 91.245

9.  New-onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: A case report.

Authors:  Keyaki Sasaki; Tomoaki Morioka; Natsumi Okada; Yuka Natsuki; Yoshinori Kakutani; Akinobu Ochi; Yuko Yamazaki; Tetsuo Shoji; Takashi Ohmura; Masanori Emoto
Journal:  J Diabetes Investig       Date:  2022-02-25       Impact factor: 3.681
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.